MY187515A - Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration - Google Patents

Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Info

Publication number
MY187515A
MY187515A MYPI2017000688A MYPI2017000688A MY187515A MY 187515 A MY187515 A MY 187515A MY PI2017000688 A MYPI2017000688 A MY PI2017000688A MY PI2017000688 A MYPI2017000688 A MY PI2017000688A MY 187515 A MY187515 A MY 187515A
Authority
MY
Malaysia
Prior art keywords
tissue
repair
alkenyl
alkyl
regeneration
Prior art date
Application number
MYPI2017000688A
Other languages
English (en)
Inventor
Gagnon Lyne
Laurin Pierre
Original Assignee
Prometic Pharma Smt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma Smt Ltd filed Critical Prometic Pharma Smt Ltd
Publication of MY187515A publication Critical patent/MY187515A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32Phenylacetic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MYPI2017000688A 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration MY187515A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12
PCT/CA2015/000572 WO2016074068A1 (en) 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Publications (1)

Publication Number Publication Date
MY187515A true MY187515A (en) 2021-09-24

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017000688A MY187515A (en) 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Country Status (19)

Country Link
US (3) US10391073B2 (cg-RX-API-DMAC7.html)
EP (1) EP3217968A4 (cg-RX-API-DMAC7.html)
JP (1) JP6720169B2 (cg-RX-API-DMAC7.html)
KR (1) KR20170072352A (cg-RX-API-DMAC7.html)
CN (1) CN107106526B (cg-RX-API-DMAC7.html)
AR (1) AR102634A1 (cg-RX-API-DMAC7.html)
AU (2) AU2015345943B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017009899A2 (cg-RX-API-DMAC7.html)
CA (1) CA2967499C (cg-RX-API-DMAC7.html)
IL (1) IL252221B (cg-RX-API-DMAC7.html)
MX (1) MX381687B (cg-RX-API-DMAC7.html)
MY (1) MY187515A (cg-RX-API-DMAC7.html)
PH (1) PH12017500856A1 (cg-RX-API-DMAC7.html)
RU (1) RU2728782C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201703741TA (cg-RX-API-DMAC7.html)
TW (1) TWI723967B (cg-RX-API-DMAC7.html)
UY (1) UY36399A (cg-RX-API-DMAC7.html)
WO (1) WO2016074068A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201703579B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
EP3217968A4 (en) * 2014-11-12 2018-06-20 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
BRPI1015124B8 (pt) 2009-05-04 2021-05-25 Prometic Biosciences Inc compostos aromáticos substituídos para a prevenção ou tratamento de distúrbios sanguíneos; distúrbios renais, nefropatias e/ou complicações do distúrbio renal; doenças relacionadas com inflamação; e distúrbios relacionados ao estresse oxidativo, usos farmacêuticos dos mesmos e composição farmacêutica comprendendo ditos compostos
JP5844251B2 (ja) * 2009-05-04 2016-01-13 プロメティック・バイオサイエンシーズ・インコーポレイテッドProMetic BioSciences Inc. 3−ペンチルフェニル酢酸の塩およびその薬学的使用
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
PT2632885T (pt) 2010-10-27 2018-04-04 Prometic Pharma Smt Ltd Compostos carboxilatos de fenilcetona e usos farmacêuticos destes
WO2012097428A1 (en) * 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and pharmaceutical compositions for uses in diabetes
KR101821646B1 (ko) 2010-10-27 2018-01-25 프로메틱 파마 에스엠티 리미티드 암을 치료하기 위한 화합물 및 조성물
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
CA2844792A1 (en) * 2011-08-10 2013-02-14 Digna Biotech, S.L. Use of cardiotrophin-1 for the treatment of kidney diseases
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
PH12017500662B1 (en) 2014-10-10 2022-08-19 Liminal Biosciences Ltd Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
MY194308A (en) 2014-10-10 2022-11-27 Prometic Pharma Smt Ltd Substituted aromatic compounds and pharmaceutical compostions for the prevention and treatment of osteoporosis
EP3217968A4 (en) * 2014-11-12 2018-06-20 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Also Published As

Publication number Publication date
AU2015345943A1 (en) 2017-06-01
PH12017500856A1 (en) 2017-11-06
CN107106526B (zh) 2021-05-28
US10869849B2 (en) 2020-12-22
AU2015345943B2 (en) 2020-03-19
RU2728782C2 (ru) 2020-07-31
JP2017533928A (ja) 2017-11-16
TW201618764A (zh) 2016-06-01
MX381687B (es) 2025-03-13
WO2016074068A1 (en) 2016-05-19
AU2020204112A1 (en) 2020-07-09
US10391073B2 (en) 2019-08-27
IL252221A0 (en) 2017-07-31
RU2017120401A3 (cg-RX-API-DMAC7.html) 2019-06-06
TWI723967B (zh) 2021-04-11
US20170312237A1 (en) 2017-11-02
IL252221B (en) 2022-04-01
SG11201703741TA (en) 2017-06-29
KR20170072352A (ko) 2017-06-26
MX2017006281A (es) 2017-08-14
US20210085626A1 (en) 2021-03-25
ZA201703579B (en) 2018-08-29
CA2967499A1 (en) 2016-05-19
UY36399A (es) 2016-06-30
EP3217968A1 (en) 2017-09-20
BR112017009899A2 (pt) 2018-01-16
US20200078324A1 (en) 2020-03-12
AU2020204112B2 (en) 2021-10-21
EP3217968A4 (en) 2018-06-20
CA2967499C (en) 2023-01-17
CN107106526A (zh) 2017-08-29
JP6720169B2 (ja) 2020-07-08
AR102634A1 (es) 2017-03-15
RU2017120401A (ru) 2018-12-13

Similar Documents

Publication Publication Date Title
CY1117080T1 (el) Θεραπευτικος παραγοντας για στενωση του σπονδυλικου σωληνα
ECSP21091615A (es) Derivados de benzisoxazol sulfonamida
CR20190483A (es) Compuestos de heteroarilo bicíclicos 6-6 fusionados y su uso como inhibidores de lats
MX2020013570A (es) Compuestos de purinona y su uso en el tratamiento del cancer.
MX2021013075A (es) Oxisteroles y metodos de uso de los mismos.
EA201991399A1 (ru) Аминотриазолопиридиновые соединения и их применение в лечении рака
CY1118129T1 (el) 5-αλκυνυλ-πυριμιδινες
BR112012016797A2 (pt) intensificador dinâmico de baixo utilizando compressor com equalizador incorporado
EA201790693A1 (ru) Коррекция фигуры
MX384868B (es) Composiciones para tratar atrofia muscular espinal.
EA201100447A1 (ru) Органические соединения
TN2016000529A1 (en) Substituted dihydroisoquinolinone compounds
CL2004000917A1 (es) Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa
BR112015001502A2 (pt) derivados de tipo azaindazol ou diazaindazol para tratamento de dor
CY1120836T1 (el) Ενωσεις 1,3,4-θειαδιαζοαης και η χρηση τους στη θεραπευτικη αντιμετωπιση του καρκινου
EA201100872A1 (ru) Производные хиназолинамида
MX381967B (es) Compuestos de 2,3-dihidrobenzofuran-5-ilo como inhibidores de quinasas dyrk.
EA201692292A1 (ru) Соединения и композиции для стимулирования хондрогенеза
EA201390626A1 (ru) Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций
UY36257A (es) “compuestos de imidazopiridazina”.
PH12018500316A1 (en) Fumagillol spirocyclic compounds and fused bicyclic compounds and their use as metap2 inhibitors
MX2017010413A (es) Compuestos de benzoxaborol y uso de los mismos.
PH12017500638A1 (en) Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
PH12017500856A1 (en) Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
MX2022006003A (es) Glucolipidos y composiciones farmaceuticas de los mismos para usarse en terapia.